Background: Cardiovascular and pulmonary diseases are common comorbidities in HIV-infected individuals. Elevated N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) is a marker of cardiac ventricular strain and systolic dysfunction and has been previously been shown to be associated with comorbidities in HIV. We aimed to determine if elevated NT-pro-BNP was associated with greater mortality in HIV-infected individuals. Methodology: NT-pro-BNP was measured from stored serum samples from a random sample of half the HIV-infected and matched on age (1:2) HIVuninfected participants in the Women’s Interagency HIV Study at two time periods: early anti-retroviral therapy (ART) (10/11/94 to 7/17/97) and late ART (4/1/08 to 10/7/08). The proportion of participants with NT-pro-BNP levels >75th percentile were compared by HIV status at each time point. Cox proportional hazards models were used to determine if an elevated NT-pro-BNP was associated with mortality independent of other covariates (age, race, body mass index, smoking status, alcohol use, illicit drug use, hepatitis C serostatus, hypertension, renal function, hemoglobin, history of AIDS, antiretroviral use, CD4 count, and viral load). Results: There were 387 HIV-uninfected and 936 HIV-infected and 448 HIV-uninfected and 1082 HIV-infected in the early and late ART periods, respectively. HIV infection was not associated with a NT-pro-BNP level in the early period, but HIV-infected persons were more likely to have a NT-pro- BNP level in the highest quartile in the late period (26.6% vs. 21.2%, unadjusted p=0.03). In HIV-infected participants, NT-pro-BNP>75th percentile was independently associated with worse survival in the 5 years subsequent to the date the sample was drawn in both the early (HR 1. 8, 95% CI 1.3-2.4, p<0.001) and late (HR 2.8, 95% CI 1.4-5.5, p=0.002) periods. The NT-pro-BNP level was not associated with mortality in HIV-uninfected women in the early period, and in the late period, there were too few deaths in the HIV-uninfected group to assess an association. Conclusions: We have identified NT-pro-BNP as a novel independent predictor of mortality in HIV-infected women. As NT-pro-BNP is often associated with cardiopulmonary dysfunction, these findings suggest that these conditions may contribute to adverse outcomes in this population.